Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Drug Promotion On The Agenda For Rep. Waxman, States

Executive Summary

Rep. Henry Waxman, D-Calif., is taking a closer look at the marketing practices of five pharmaceutical companies, a probe that follows several state lawsuits over off-label drug promotion

You may also be interested in...



FDA’s Off-Label Dissemination Guidance Opens “Loophole” – Rep. Waxman

Rep. Henry Waxman, D-Calif., made another move in his fight against off-label drug promotion Nov. 30, releasing an internal FDA 1draft guidance on "good reprint practices" and sending a strongly worded 2letter to Commissioner Andrew von Eschenbach

FDA’s Off-Label Dissemination Guidance Opens “Loophole” – Rep. Waxman

Rep. Henry Waxman, D-Calif., made another move in his fight against off-label drug promotion Nov. 30, releasing an internal FDA 1draft guidance on "good reprint practices" and sending a strongly worded 2letter to Commissioner Andrew von Eschenbach

Off-Label Dissemination May Be Clarified – Indirectly – By FDAAA Regs

Issues surrounding off-label dissemination may be clarified through regulations required by the FDA Amendments Act of 2007

UsernamePublicRestriction

Register

MT003605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel